IRIS Accounts Production v24.3.0.553 NI065204 Board of Directors Board of Directors 1.10.23 30.9.24 30.9.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhNI0652042023-09-30NI0652042024-09-30NI0652042023-10-012024-09-30NI0652042022-09-30NI0652042022-10-012023-09-30NI0652042023-09-30NI065204ns15:NorthernIreland2023-10-012024-09-30NI065204ns14:PoundSterling2023-10-012024-09-30NI065204ns10:Director12023-10-012024-09-30NI065204ns10:Director22023-10-012024-09-30NI065204ns10:PrivateLimitedCompanyLtd2023-10-012024-09-30NI065204ns10:SmallEntities2023-10-012024-09-30NI065204ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-30NI065204ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-30NI065204ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-30NI065204ns10:FullAccounts2023-10-012024-09-30NI06520412023-10-012024-09-30NI065204ns10:CompanySecretary12023-10-012024-09-30NI065204ns10:RegisteredOffice2023-10-012024-09-30NI065204ns5:CurrentFinancialInstruments2024-09-30NI065204ns5:CurrentFinancialInstruments2023-09-30NI065204ns5:ShareCapital2024-09-30NI065204ns5:ShareCapital2023-09-30NI065204ns5:RetainedEarningsAccumulatedLosses2024-09-30NI065204ns5:RetainedEarningsAccumulatedLosses2023-09-30NI065204ns5:NetGoodwill2023-10-012024-09-30NI065204ns5:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-30NI065204ns5:NetGoodwill2023-09-30NI065204ns5:NetGoodwill2024-09-30NI065204ns5:NetGoodwill2023-09-30NI065204ns5:PlantMachinery2023-09-30NI065204ns5:PlantMachinery2023-10-012024-09-30NI065204ns5:PlantMachinery2024-09-30NI065204ns5:PlantMachinery2023-09-30NI065204ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-09-30NI065204ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-10-012024-09-30NI065204ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-09-30NI065204ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-09-30NI065204ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-30NI065204ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30
REGISTERED NUMBER: NI065204 (Northern Ireland)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

POND PARK PHARMACY LIMITED

POND PARK PHARMACY LIMITED (REGISTERED NUMBER: NI065204)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 7


POND PARK PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: Mrs A Mallon
Ms A Rooney





SECRETARY: H V Rooney





REGISTERED OFFICE: 17 Clarendon Road
Clarendon Dock
Belfast
BT1 3BG





REGISTERED NUMBER: NI065204 (Northern Ireland)





ACCOUNTANTS: Baker Tilly Mooney Moore
17 Clarendon Road
Clarendon Dock
Belfast
BT1 3BG

POND PARK PHARMACY LIMITED (REGISTERED NUMBER: NI065204)

BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 179,945 239,927
Tangible assets 5 42,272 55,975
222,217 295,902

CURRENT ASSETS
Stocks 100,285 101,670
Debtors 6 241,668 205,006
Cash at bank and in hand 227,688 203,787
569,641 510,463
CREDITORS
Amounts falling due within one year 7 476,915 445,026
NET CURRENT ASSETS 92,726 65,437
TOTAL ASSETS LESS CURRENT
LIABILITIES

314,943

361,339

PROVISIONS FOR LIABILITIES 10,839 10,839
NET ASSETS 304,104 350,500

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 304,004 350,400
304,104 350,500

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

POND PARK PHARMACY LIMITED (REGISTERED NUMBER: NI065204)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 December 2024 and were signed on its behalf by:




Mrs A Mallon - Director



Ms A Rooney - Director


POND PARK PHARMACY LIMITED (REGISTERED NUMBER: NI065204)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Pond Park Pharmacy Limited is a private company, limited by shares , registered in Northern Ireland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In preparing these financial statements the directors have made the following judgements in:

The need for impairment provisions against items held in stock. These considerations are undertaken regularly by the directors, and especially at the year end date. Factors taken into account include historical experience, current market conditions and knowledge of the sector. Amounts identified as irrecoverable will be provided against in the relevant period.

The directors also consider the depreciation rates and useful lives on an annual basis to ensure there is sufficient evidence to support these and that the estimates remain reasonable.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2007, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Fixtures and Fittings - 25% reducing balance
Leasehold Improvements - 10% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

POND PARK PHARMACY LIMITED (REGISTERED NUMBER: NI065204)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued

Financial instruments
All financial instruments of the company are considered to meet the definition of basic financial instruments.

- Short term debtors and creditors
Debtors and creditors with no stated interest rate and are receivable or payable on demand are recognised at transaction price, and subject to annual impairment reviews. Any losses arising on impairment are recognised in the profit and loss account.

- Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2023 - 18 ) .

POND PARK PHARMACY LIMITED (REGISTERED NUMBER: NI065204)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 October 2023
and 30 September 2024 1,192,804
AMORTISATION
At 1 October 2023 952,877
Charge for year 59,982
At 30 September 2024 1,012,859
NET BOOK VALUE
At 30 September 2024 179,945
At 30 September 2023 239,927

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023
and 30 September 2024 253,432
DEPRECIATION
At 1 October 2023 197,457
Charge for year 13,703
At 30 September 2024 211,160
NET BOOK VALUE
At 30 September 2024 42,272
At 30 September 2023 55,975

POND PARK PHARMACY LIMITED (REGISTERED NUMBER: NI065204)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 October 2023
and 30 September 2024 123,085
DEPRECIATION
At 1 October 2023 96,317
Charge for year 6,692
At 30 September 2024 103,009
NET BOOK VALUE
At 30 September 2024 20,076
At 30 September 2023 26,768

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 201,848 166,637
Other debtors 39,820 38,369
241,668 205,006

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Bank loans and overdrafts 70,500 85,822
Hire purchase contracts - 18,586
Trade creditors 312,840 270,980
Tax 75,864 49,185
Social security and other taxes 4,573 3,117
Directors' current accounts 5,235 5,319
Accrued expenses 7,903 12,017
476,915 445,026